Search UK public tenders and contract notices
Official notices, one row per procedure. Filters use published facts only: delivery region from the notice, buyer type from the official classification, route and agreement type as published, never a Tenderline score.
Retenders uses the same keywords and compatible filters. Notice-only filters and CPV detail beyond the division do not carry over.
All records
Showing 391–405 · every procedure in the catalogue, any stage.
- AwardedOpen procedure
Needle Pack Provider
East Riding of Yorkshire Council · Local authority · Yorkshire and the Humber
This contract is for a needle pack provider to provide needle and syringe programme (NSP) equipment to pharmacies, direct to people who inject drugs via postal needle exchange, and to the Public Health commissioned drug and alcohol treatmen…
Awarded to Frontier NX Ltd
- Value
- £175k
- Term
- 3 years
- Submit via
- EU-Supply (CTM)public page
- Published
- #04794e
- Awarded
Rituximab Subcut
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Awarded to Roche Products Ltd · 2 awards
- Value
- Not published
- Term
- 4 years
- Submit via
- portal not identified
- Published
- #046c75
- AwardedAward procedure without prior publication of a call for competitionFramework
Trastuzumab (Herceptin®) 600mg/5ml solution for Injection
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Trastuzumab (Herceptin®) 600mg/5ml solution for Injection to NHS Scotland
Awarded to Roche Products Ltd · 4 awards
- Value
- Not published
- Term
- 4 years
- Submit via
- portal not identified
- Published
- #029a9d
- AwardedOpen procedureFramework6 lots
NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers
NHS England · NHS & health · Nationwide (UK)
NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers.<br/>Period of framework agreement: 1st February 2025 to 31st January 2027, with an option or options to extend (at the discretion of the Authority) f…
Awarded to Abbvie Ltd, Baxter Healthcare Ltd, Piramal Critical Care Ltd · 5 awards
- Value
- £35mceiling, not a contract size
- Term
- 2 years
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #04b462
- AwardedCompetitive procedure with negotiation
Clinical Trial Manufacturing and Distribution Services
Nottingham Trent University · Education · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
Nottingham Trent University required Clinical Trial Manufacturing and Distribution Services for manufacturing and distribution of fluoxetine (20mg) and a matching placebo.
Awarded to Sharp Clinical Services UK Ltd.
- Value
- £345k
- Term
- 4 years
- Submit via
- EU-Supply (CTM)public page
- Published
- #0458a3
- Planned · expected · not yet publishedFrameworkSME suitable
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · Central government · Nationwide (UK)
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal …
- Value
- £1.5bnceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- portal not identified
- Published
- #04f70b
- Planned · expected · not yet publishedFrameworkSME suitable
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · Central government · Nationwide (UK)
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal …
- Value
- £1.5bnceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- portal not identified
- Published
- #04f708
- Planned · expected · not yet publishedFrameworkSME suitable
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · Central government · Nationwide (UK)
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal …
- Value
- £1.5bnceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- portal not identified
- Published
- #04f707
- Planned · expected · not yet publishedFrameworkSME suitable
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · Central government · Nationwide (UK)
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal …
- Value
- £1.5bnceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- portal not identified
- Published
- #04f706
- Planned · expected · not yet publishedFrameworkSME suitable
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · Central government · Nationwide (UK)
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal …
- Value
- £1.5bnceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- portal not identified
- Published
- #04f704
- Planned · expected · not yet publishedFrameworkSME suitable
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England · Central government · Nationwide (UK)
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal …
- Value
- £1.5bnceiling, not a contract size
- Term
- 18 monthsup to 3.5 years with extensions
- Submit via
- portal not identified
- Published
- #04f703
- PlannedSME · VCSE suitable
Supply of Nutritional Products
NHS England · Central government · delivery region not published
Interested suppliers are asked to complete a Request for Information (RFI) This RFI seeks to improve our understanding about the market and focuses on 4 key areas: 1. UK nutrition market overview 2. UK nutrition market and current commercia…
- Value
- £0
- Term
- 11 days
- Submit via
- portal not identified
- Published
- #04ef98
- AwardedOpen procedureFramework7 lots
NP47924 Cytokine Modulators
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Cytokine Modulators to NHS Scotland.
Awarded to Accord Healthcare Ltd, Biogen Idec Ltd, Celltrion Healthcare United Kingdom Limited +5 more · 7 awards
- Value
- Not published
- Term
- 2 years
- Submit via
- Public Contracts Scotlandlogin required
- Published
- #04b34f
- AwardedRestricted procedure
Pralidoxime Chloride
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · NHS & health · Nationwide (UK)
A procurement for the supply of pralidoxime chloride
Awarded to Baxter Healthcare Ltd
- Value
- Not published
- Term
- 4 years
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #0498d6
- AwardedOpen procedureFramework
NHS National Framework for the supply of Pomalidomide commencing 1 April 2025
NHS England · NHS & health · Nationwide (UK)
Project title: NHS National Framework for the supply of Pomalidomide commencing 1 April 2025<br/>Offer reference number: CM/TNS/24/5719<br/><br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at th…
Awarded to Amarox Limited, Grindeks Kalceks UK Ltd, Thornton and Ross Ltd +2 more · 15 awards
- Value
- £95mceiling, not a contract size
- Term
- 14 months
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- #04c0e1